Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience

BACKGROUND: In resource-constrained areas, generic direct-acting antivirals (DAAs) have considerably reduced the cost of hepatitis C virus (HCV) therapy while there remain significant costs related to the baseline and follow-up virologic assays. AIM: The aim was to assess the efficacy and safety of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hepatol
Main Authors: Bwa, Aung H., Nangia, Gayatri, Win, Si T.S., Maung, Soe T., Han, Khin A.W., Htar, Su S., Wine, Lei Y., Ko, Wint W., Oo, Moe P., Hlaing, Naomi K.T., Palecki, Julia, Loza, Bao L., Win, Khin M., Reddy, Rajender
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6637231/
https://ncbi.nlm.nih.gov/pubmed/31360020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.12.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados